Authors:
Southey, MC
Young, MA
Whitty, J
Mifsud, S
Keilar, M
Mead, L
Trute, L
Aittomaki, K
McLachlan, SA
Debinski, H
Venter, DJ
Armes, JE
Citation: Mc. Southey et al., Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis, AM J SURG P, 25(7), 2001, pp. 936-941
Authors:
Brown, GJE
St John, DJB
Macrae, FA
Aittomaki, K
Citation: Gje. Brown et al., Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: Implications for gynecologic surveillance, GYNECOL ONC, 80(3), 2001, pp. 346-349
Authors:
Vahteristo, P
Tamminen, A
Karvinen, P
Eerola, H
Eklund, C
Aaltonen, LA
Blomqvist, C
Aittomaki, K
Nevanlinna, H
Citation: P. Vahteristo et al., p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition, CANCER RES, 61(15), 2001, pp. 5718-5722
Authors:
Kiuru, M
Launonen, V
Hietala, M
Aittomaki, K
Vierimaa, O
Salovaara, R
Arola, J
Pukkala, E
Sistonen, P
Herva, R
Aaltonen, LA
Citation: M. Kiuru et al., Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology, AM J PATH, 159(3), 2001, pp. 825-829
Authors:
Meiser, B
Butow, P
Barratt, A
Friedlander, M
Kirk, J
Gaff, C
Haan, E
Aittomaki, K
Tucker, K
Citation: B. Meiser et al., Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer, BREAST CANC, 59(2), 2000, pp. 101-111
Authors:
Jiang, N
Aittomaki, K
Nilsson, C
Pakarinen, P
Iitia, A
Torresani, T
Simonsen, K
Goh, V
Pettersson, K
de la Chapelle, A
Huhtaniemi, I
Citation: N. Jiang et al., The frequency of an inactivating point mutation (C-566 -> T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry, J CLIN END, 83(12), 1998, pp. 4338-4343